CVS Health has added four new board members, including the chief executive of a hedge fund that has been critical of the struggling healthcare giant. The company said Monday that it expanded its board to 16 members following “productive discussions” with shareholder Glenview Capital Management.

CVS Health said four new members will be added to its board from the hedge fund Glenview Capital, which had been pushing for changes at the diversified healthcare giant.

CVS Health added Glenview Capital's top boss and three others to its board in a deal with the hedge fund, a month after the healthcare conglomerate tasked a new CEO with its turnaround efforts.

CVS Health adds four new board members after engagement with activist investor Glenview Capital Management, boosting shareholder value.

CVS Health has added four new board members, including the CEO of a hedge fund that has been critical of the struggling health care giant. The company said Monday that it expanded its board to 16 members following “productive discussions” with shareholder Glenview Capital Management.

CVS Health said on Monday it would add four new members to its board in an agreement with Glenview Capital Management, including the hedge fund's chief executive Larry Robbins. Longtime investor Glenview Capital Management bought 2.

Shares of CVS Health (NYSE:CVS) rose 2.8% in premarket trading on Monday following a report from the Wall Street Journal that the company will expand its board as part of an agreement with Glenview Capital Management,